Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Optomed financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
€3.8
2024-10-29
Market Capitalization
€74 M
2024-10-29
Revenue
€17.1 M
FY, 2025
CreditSafe Score
?
Score changed on Jun 04, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| EUR | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | 15.0M | 13.0M | 14.9M | 14.7M | 15.1M | 15.0M | 17.1M |
| Cost of goods sold | 5.3M | 4.2M | 5.1M | 5.4M | 4.9M | 5.4M | 6.2M |
| Gross profit | 9.9M | 9.0M | 10.6M | 10.1M | 10.3M | 9.7M | 10.9M |
| Gross profit margin, % | 66.4% | 68.8% | 71.1% | 68.7% | 68.2% | 64.3% | 63.6% |
| Operating expense total | 10.3M | 9.7M | 11.9M | 12.1M | 11.9M | 13.9M | 14.4M |
| Depreciation and amortization | 2.3M | 2.2M | 2.8M | 3.1M | 2.2M | 2.5M | 2.5M |
| EBITDA | (335.0K) | (733.0K) | (1.3M) | (2.1M) | (1.6M) | (4.3M) | (3.5M) |
| EBITDA margin, % | -2.2% | -5.6% | -8.7% | -14.2% | -10.4% | -28.3% | -20.3% |
| EBIT | (2.6M) | (2.9M) | (4.8M) | (5.1M) | (4.0M) | (6.0M) | (6.0M) |
| EBIT margin, % | -17.3% | -22.3% | -32.2% | -34.8% | -26.3% | -39.6% | -35.1% |
| Interest income | 3.0K | 8.0K | 17.0K | 4.0K | 23.0K | 181.0K | 115.0K |
| Interest expense | 365.0K | 328.0K | 165.0K | 268.0K | 288.0K | 614.0K | 667.0K |
| Pre tax profit | (3.0M) | (3.2M) | (4.3M) | (5.6M) | (4.5M) | (5.5M) | (6.7M) |
| Income tax expense | (77.0K) | (70.0K) | (78.0K) | (79.0K) | (78.0K) | (66.0K) | (78.0K) |
| Net Income | (2.9M) | (3.2M) | (4.2M) | (5.5M) | (4.4M) | (5.4M) | (6.6M) |